Skin infections are common occurrences that can result from various types of injuries, such as scratches, scrapes, bites, and puncture wounds. These injuries may lead to bacterial infections characterised by pain, swelling, and the potential for further complications if not appropriately treated.
Among the topical antibiotics available for managing skin infections, fusidic acid emerges as a first-choice option due to its unique properties and effectiveness against key bacterial pathogens.
Fusidic acid, a steroidal antibiotic, is particularly effective against Staphylococcus aureus, including methicillin-resistant strains (MRSA). It functions by inhibiting bacterial protein synthesis, thereby preventing the replication and spread of bacteria. This mechanism is crucial for tackling infections caused by bacteria that have developed resistance to other antibiotic classes. Unlike some antibiotics that indiscriminately target a broad range of bacteria, fusidic acid offers a more targeted approach, minimising disruption to the beneficial skin microbiota.
Pharmacists play a vital role in advising patients on the appropriate use of fusidic acid. It is commonly formulated in creams or ointments, which should be applied directly to the infected area. The typical course of treatment spans one to two weeks, depending on the severity and nature of the infection. It’s important to educate patients on adhering strictly to the prescribed duration of therapy to prevent resistance development.
One of the major advantages of fusidic acid is its safety profile. Adverse effects are relatively rare, with contact dermatitis being the most commonly reported. However, this is generally mild and resolves upon discontinuation. You should nonetheless be vigilant in monitoring for side effects and advise patients to report any unexpected skin reactions.
Moreover, fusidic acid's effectiveness is not diminished by the presence of pus or debris at the infection site, making it suitable for a variety of superficial skin infections. This characteristic differentiates it from some other topical antibiotics that may become less effective in such conditions.
In summary, fusidic acid is a preferred topical antibiotic for treating skin infections owing to its targeted action against resistant bacteria, excellent safety profile, and potency even in varied environmental conditions. For pharmacists, understanding the nuances of fusidic acid application ensures patients receive effective, informed care in managing skin infections, optimising therapeutic outcomes, and contributing to the broader antimicrobial stewardship efforts by reducing the likelihood of resistance development through improper antibiotic use.
REFERENCES:
- Belseck N. Why fusidic acid is the first-choice option in the treatment of skin infections. Pharmacy Magazine. July 2022. Available from: https://www.medicalacademic.co.za/dermatology/why-fusidic-acid-is-the-first-choice-option-in-the-treatment-of-skin-infections/
- Bosman R. Fusidic acid – first-choice option in the treatment of skin infection. Specialist Forum. Available from: https://www.medicalacademic.co.za/dermatology/fusidic-acid-first-choice-option-in-the-treatment-of-skin-infection/
